Maravai shareholders elect directors, ratify auditor, approve executive compensation at 2024 annual meeting

MARAVAI LIFESCIENCES HOLDINGS, INC.

Elected four director nominees: Benjamin Daverman, Susannah Gray, Carl Hull, Constantine Mihas to three-year terms.
Ratified Ernst & Young LLP as independent auditor for FY 2024 with 236,288,478 votes for, 268,742 against.
Non-binding advisory approval of named executive officer compensation with 223,303,654 votes for.
Quorum met with 236,931,940 shares represented out of 251,748,827 outstanding.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.